mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 85 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 832,042 | 0 | C | G | 66.7% | ‑3.2 / 10.2 | 15 | A79G (GCG→GGG) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 66.0% | ‑0.5 / 41.8 | 50 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 822,963 | 0 | T | G | 64.7% | ‑1.9 / 15.5 | 17 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 2,636,048 | 0 | T | G | 61.5% | 10.2 / 29.2 | 26 | A52A (GCA→GCC) | rodZ | cytoskeleton protein RodZ |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 61.2% | ‑6.2 / 44.8 | 50 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 822,955 | 0 | T | G | 61.1% | 13.2 / 19.4 | 18 | T495P (ACC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 5,159 | 0 | G | A | 59.1% | 0.6 / 22.5 | 22 | intergenic (+139/‑75) | thrC/yaaX | threonine synthase/DUF2502 domain‑containing protein |
| * | NZ_CP009273 | 3,348,801 | 0 | G | A | 58.8% | ‑1.1 / 14.6 | 17 | E240K (GAA→AAA) | gltB | glutamate synthase large subunit |
| * | NZ_CP009273 | 4,290,979 | 0 | T | G | 58.3% | 21.1 / 27.3 | 24 | T639T (ACA→ACC) | mdtO | multidrug efflux transporter permease subunit MdtO |
| * | NZ_CP009273 | 937,169 | 0 | T | G | 57.1% | 5.4 / 25.8 | 21 | V252G (GTG→GGG) | dmsA | dimethylsulfoxide reductase subunit A |
| * | NZ_CP009273 | 2,871,023 | 0 | A | G | 57.1% | 0.6 / 15.2 | 14 | intergenic (+46/+905) | iap/cas2e | alkaline phosphatase isozyme conversion aminopeptidase/type I‑E CRISPR‑associated endoribonuclease Cas2e |
| * | NZ_CP009273 | 4,527,926 | 0 | A | C | 57.1% | 19.7 / 35.0 | 28 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
| * | NZ_CP009273 | 228,191 | 0 | A | G | 56.5% | 12.1 / 24.5 | 23 | S195G (AGC→GGC) | yafD | endonuclease/exonuclease/phosphatase family protein |
| * | NZ_CP009273 | 2,636,054 | 0 | A | T | 56.5% | 11.3 / 25.9 | 23 | D50E (GAT→GAA) | rodZ | cytoskeleton protein RodZ |
| * | NZ_CP009273 | 701,009 | 0 | T | A | 55.6% | 0.9 / 18.1 | 18 | I537N (ATC→AAC) | nagE | PTS N‑acetyl glucosamine transporter subunit IIABC |
| * | NZ_CP009273 | 832,048 | 0 | T | G | 55.6% | 18.4 / 24.0 | 18 | V81G (GTC→GGC) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 5,162 | 0 | T | A | 55.0% | 14.3 / 25.5 | 21 | intergenic (+142/‑72) | thrC/yaaX | threonine synthase/DUF2502 domain‑containing protein |
| * | NZ_CP009273 | 1,695,560 | 0 | T | C | 55.0% | 20.4 / 27.3 | 20 | I116T (ATC→ACC) | malY | bifunctional maltose regulon transcriptional repressor/cystathionine beta‑lyase MalY |
| * | NZ_CP009273 | 3,175,946 | 0 | C | G | 55.0% | 5.6 / 17.6 | 20 | A13G (GCA→GGA) | zupT | zinc transporter ZupT |
| * | NZ_CP009273 | 3,436,636 | 0 | A | C | 55.0% | 10.8 / 27.2 | 20 | V274G (GTA→GGA) | secY | preprotein translocase subunit SecY |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP009273 | 4532499 = | 15 (0.490) | 4 (0.150) | 4/152 | 1.9 | 14.7% | intergenic (+49/‑433) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
| ? | NZ_CP009273 | 4532813 = | 33 (1.210) | intergenic (+363/‑119) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA | |||||